Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
06/08/2006 | CA2589638A1 7-membered ring compound and method of production and pharmaceutical application thereof |
06/08/2006 | CA2589433A1 Inducible nitric oxide synthase dimerization inhibitors |
06/08/2006 | CA2589010A1 Biaryloxymethylarene carboxylic acids |
06/08/2006 | CA2588949A1 Compounds with mixed pde-inhibitory and .beta.-adrenergic antagonist or partial agonist activity for treatment of heart failure |
06/08/2006 | CA2588947A1 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
06/08/2006 | CA2588867A1 Substituted pyridone derivative |
06/08/2006 | CA2588864A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
06/08/2006 | CA2586334A1 Compounds for the treatment of cns and amyloid associated diseases |
06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
06/07/2006 | EP1666477A1 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) q uinolonecarboxylic acid derivative |
06/07/2006 | EP1666469A1 Plasminogen activator inhibitor-1 inhibitor |
06/07/2006 | EP1666462A1 N-[1h-indol-5-yl]naphthalene-1-sulphonamide derivatives and related compounds as serotonin 5-ht6 receptor antagonists for the treatment of disorders of the central nervous system |
06/07/2006 | EP1666038A1 Method of stabilizing lipid-rich plaque and method of preventing rupture thereof |
06/07/2006 | EP1664092A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
06/07/2006 | EP1664088A2 Hemiasterlin derivatives and uses thereof |
06/07/2006 | EP1664036A1 Benzimidazolone compounds having 5-ht4 receptor agonistic activity |
06/07/2006 | EP1664031A2 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors |
06/07/2006 | EP1664030A1 Quinazoline derivatives |
06/07/2006 | EP1664029A1 Quinazoline derivatives as antitumor agents |
06/07/2006 | EP1664028A1 Quinazoline derivatives as tyrosine kinase inhibitors |
06/07/2006 | EP1664027A1 Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use |
06/07/2006 | EP1664026A1 Mitotic kinesin inhibitors |
06/07/2006 | EP1664025A1 Pyrrol derivatives with antibacterial activity |
06/07/2006 | EP1664024A1 Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors |
06/07/2006 | EP1664023A1 Sustituted isoquinoline derivatives and methods of use |
06/07/2006 | EP1664022A1 2-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
06/07/2006 | EP1664021A1 N-substituted benzimidazolyl c-kit inhibitors |
06/07/2006 | EP1664020A1 New salts of omeprazole and esomeprazole ii |
06/07/2006 | EP1664019A1 New salts of omerazole and esomerazole i |
06/07/2006 | EP1664018A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
06/07/2006 | EP1664017A1 Benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors |
06/07/2006 | EP1664016A2 Therapeutic agents useful for treating pain |
06/07/2006 | EP1664010A1 Sulfonamides antagonising n-type calcium channels |
06/07/2006 | EP1663996A1 (thio)carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists |
06/07/2006 | EP1663994A1 Condensed pyrimidine compounds as inhibitors of voltage-gated ion channels |
06/07/2006 | EP1663992A1 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
06/07/2006 | EP1663988A1 Benzyl-benzimidazolyl derivatives |
06/07/2006 | EP1663987A1 Ophthalmic compositions for treating ocular hypertension |
06/07/2006 | EP1663986A1 Pesticidal 5-substituted-oxyalkylamino-1-arylpyrazole derivatives |
06/07/2006 | EP1663985A1 Pesticides |
06/07/2006 | EP1663979A1 Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists |
06/07/2006 | EP1663976A1 4-pyridinylmethyl sulfonamide derivatives as fungicidal plant protection agents |
06/07/2006 | EP1663975A1 Novel gamma secretase inhibitors |
06/07/2006 | EP1663974A1 2-pyridone derivatives as netrophil elastase inhibitors and their use |
06/07/2006 | EP1663973A1 2-pyridone derivatives as neutrophil elastase inhibitors and their use |
06/07/2006 | EP1663971A1 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists |
06/07/2006 | EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
06/07/2006 | EP1663248A1 7-heteroarylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
06/07/2006 | EP1663241A1 5-arylpyrimidines as anticancer agents |
06/07/2006 | EP1663237A2 Fused ring heterocycles as potassium channel modulators |
06/07/2006 | EP1663234A1 Piperazine derivatives for the treatment of hiv infections |
06/07/2006 | EP1663228A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
06/07/2006 | EP1663227A2 Dihydropyridine compounds for treating or preventing metabolic disorders |
06/07/2006 | EP1663223A2 Thalidomide analogs as tnf-alpha modulators |
06/07/2006 | EP1663211A1 Aminotriazole compounds useful as inhibitors of protein kinases |
06/07/2006 | EP1663210A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
06/07/2006 | EP1663204A2 C-kit modulators and methods of use |
06/07/2006 | EP1663202A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp) |
06/07/2006 | EP1425029A4 Peptidomimetics of biologically active metallopeptides |
06/07/2006 | EP1421075B1 Piperidine derivatives useful as ccr5 antagonists for the treatment of hiv |
06/07/2006 | EP1406878B1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
06/07/2006 | EP1355889B1 Substituted triazole diamine derivatives as kinase inhibitors |
06/07/2006 | EP1309559B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
06/07/2006 | EP1259489B1 Aryl fused azapolycyclic compounds |
06/07/2006 | EP1148783B1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors |
06/07/2006 | EP1056725B1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |
06/07/2006 | CN1784396A P38 inhibitors and methods of use thereof |
06/07/2006 | CN1784395A Piperazine-alkyl-ureido derivatives |
06/07/2006 | CN1784394A Novel piperidine derivatives |
06/07/2006 | CN1784393A Chemical compounds |
06/07/2006 | CN1784391A Quinazolines useful as modulators of ion channels |
06/07/2006 | CN1784389A Pyrimidine compounds and pests controlling composition containing the same |
06/07/2006 | CN1784388A Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same |
06/07/2006 | CN1784387A Benzimidazole derivatives |
06/07/2006 | CN1784386A 1,2-diarylimidazoles useful as inhibitors of COX |
06/07/2006 | CN1784382A 7-amino- isoindolyl compounds amd their pharmaceutical uses |
06/07/2006 | CN1783010A Program code size partitioning system and method for multiple memory multi-processing systems |
06/07/2006 | CN1781918A Process for producing thioester compound |
06/07/2006 | CN1781903A Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof |
06/07/2006 | CN1258531C Aminomethyl pyrrolidine derivatives having aromatic substituents |
06/07/2006 | CN1258529C Process for preparing diaryl-4-amino-piperidinyl compounds |
06/06/2006 | US7057049 Mitogen-activated protein kinase inhibitors |
06/06/2006 | US7057048 Androgen receptor antagonists |
06/06/2006 | US7057046 Lactam glycogen phosphorylase inhibitors and method of use |
06/06/2006 | US7057038 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids |
06/06/2006 | US7057035 reacting aryl/heteroaryl triflate/halide with carbon monoxide and N-hydroxysuccinimide in solvent in presence of palladium catalyst and base |
06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
06/06/2006 | US7056941 for efficient control of animal pests from the class of insects, arachnids and nematodes, for controlling broad spectrum of phytopathogenic fungi, in particular from the class of the Ascomycetes, Deuteromycetes, Phycomycetes and Basidiomycetes |
06/06/2006 | US7056937 Sulfonylquinoxalone derivatives as bradykinin antagonists |
06/06/2006 | US7056935 Administering to the animal suffering from neurological disorders an amide compound having an affinity for FKBP-type immunophilins |
06/06/2006 | US7056934 use in treating respiratory system disorders such as asthma, incipient asthma and wheezy infant syndrome, chronic or acute bronchoconstriction, chronic bronchitis, small airways obstruction, emphysema, chronic eosinophilic pneumonia, chronic obstructive pulmonary disease, allergies |
06/06/2006 | US7056933 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc. |
06/06/2006 | US7056932 Heterocyclyl substituted 1-alkoxy acetic acid amides |
06/06/2006 | US7056926 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis |
06/06/2006 | US7056925 Urea kinase inhibitors |
06/06/2006 | US7056923 Anticoagulants |
06/06/2006 | US7056922 Acylamino cyclopropane derivatives |
06/06/2006 | US7056918 Benzimidazole anti-inflammatory compounds |
06/06/2006 | US7056915 Compounds useful as reversible inhibitors of cysteine proteases |
06/06/2006 | US7056913 for example, 7-methoxy-8-[n'-(4''-acridonylcarboxyamido)alkyl]-oxy-(11aS)-1,2,3,11a-tetraydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one; antitumor agents |